Piper Sandler Reiterates Overweight Rating on Amgen (AMGN) Jun 12, 2026 08:25AM
Amgen (AMGN) PT Raised to $340 at Morgan Stanley Jun 9, 2026 04:38PM
AMGEN's Repatha shows 29% cardiovascular event reduction in diabetes study Jun 8, 2026 02:56AM
Kissei Pharmaceutical warns against new TAVNEOS prescriptions amid safety concerns May 15, 2026 03:50PM
Amgen (AMGN) PT Lowered to $427 at Piper Sandler May 14, 2026 08:25AM
View Older Stories

May 7, 2026 08:30AM Freedom Broker Upgrades Amgen (AMGN) to Buy
May 5, 2026 06:16AM Erste Group Downgrades Amgen (AMGN) to Hold
May 4, 2026 09:01AM AMGEN announces $300 million US manufacturing investment
May 4, 2026 07:24AM Amgen (AMGN) PT Lowered to $340 at Guggenheim
May 1, 2026 05:59AM Amgen (AMGN) PT Raised to $307 at BofA Securities
Apr 30, 2026 04:03PM Amgen (AMGN) Tops Q1 EPS by 35c, Offers Guidance
Apr 30, 2026 03:30AM Amgen (AMGN) call put ratio 1.5 calls to 1 put with a focus on May 365 calls into quarter results
Apr 29, 2026 11:23AM Amgen (AMGN) call put ratio 1.6 calls to 1 put into quarter results
Apr 28, 2026 01:46PM AstraZeneca, Amgen partner with FDA to test real-time AI trial monitoring
Apr 20, 2026 04:12PM Canaccord Starts Amgen (AMGN) at Hold
Apr 13, 2026 09:34AM Amgen (AMGN) PT Raised to $400 at UBS
Apr 9, 2026 07:10AM Amgen (AMGN) PT Raised to $351 at Guggenheim
Apr 8, 2026 09:15AM Amgen (AMGN) PT Raised to $325 at Truist Securities
Apr 8, 2026 07:41AM Amgen (AMGN) Reiterated at Neutral by Cantor Fitzgerald Amid Negative/Neutral Sentiment
Apr 6, 2026 12:41PM William Blair on Amgen (AMGN): top-line results show 'strong efficacy' compared to VRDN data
Apr 6, 2026 09:46AM Stifel on Viridian (VRDN): 'We view positive REVEAL-2 chronic TED data in 2Q26 as important'
Apr 2, 2026 08:07AM RBC Capital: 'Amgen (AMGN) Highlights Key Growth Drivers For The Rest Of 2026 And Beyond'
Mar 31, 2026 03:14PM Amgen’s Tavneos Tied to Deaths, Liver Injury - FDA
Mar 30, 2026 04:38PM Jefferies on Amgen (AMGN): Elegrobart data not a 'significant competitive threat to Tepezza'
Mar 10, 2026 05:38AM Jefferies Starts Amgen (AMGN) at Hold
Mar 10, 2026 05:38AM Jefferies Starts Vertex (VRTX) at Buy
Mar 10, 2026 05:38AM Jefferies Starts Gilead Sciences (GILD) at Buy
Mar 9, 2026 10:53AM FDA: 'The agency today is withdrawing final guidance titled “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product'
Mar 5, 2026 04:16PM Leerink Partners Reiterates Market Perform Rating on Amgen (AMGN), lowers estimates
Mar 4, 2026 04:02PM Amgen (AMGN) Declares $2.52 Quarterly Dividend; 2.7% Yield
Feb 20, 2026 07:54AM Barclays Starts Amgen (AMGN) at Equalweight
Feb 19, 2026 08:58AM TD Cowen on Amgen's (AMGN) Dazodalibep: 'An Overlooked Gem In Amgen's Pipeline?'
Feb 18, 2026 07:21AM Amgen (AMGN) PT Raised to $432 at Piper Sandler
Feb 13, 2026 04:50PM Amgen (AMGN) files mixed shelf
Feb 12, 2026 03:54PM Freedom Capital Markets Downgrades Amgen (AMGN) to Hold (mid morning)
Feb 6, 2026 07:29AM Amgen (AMGN) PT Raised to $347 at Guggenheim
Feb 4, 2026 12:27PM BofA on Amgen (AMGN): 'Catalysts: pelacarsen readthrough shifts to mid-2026'
Feb 4, 2026 09:59AM Amgen (AMGN) PT Raised to $350 at Cantor Fitzgerald
Feb 4, 2026 08:10AM Amgen (AMGN) PT Raised to $360 at RBC Capital
Feb 4, 2026 05:37AM Amgen (AMGN) PT Raised to $420 at TD Cowen
Feb 3, 2026 04:30PM After-hours movers: AMD, Chipotle, Lumentum, Silicon Labs and more
Feb 3, 2026 04:02PM Amgen (AMGN) Tops Q4 EPS by 56c, Beats on Revenue; Offers FY26 Guidance
Feb 3, 2026 10:32AM Amgen (AMGN) call put ratio 1 call to 1 put into quarter results
Feb 3, 2026 05:37AM Amgen (AMGN) call put ratio 1.1 calls to 1 put into quarter results
Feb 2, 2026 10:30AM Amgen (AMGN) call put ratio 2.3 calls to 1 put into quarter results
Feb 2, 2026 05:09AM Amgen (AMGN) call put ratio 1 call to 1.4 puts into quarter results
Jan 30, 2026 11:17AM Amgen (AMGN) call put ratio 1 call to 1.6 puts into quarter results
Jan 21, 2026 10:00AM This U.S. biotech stock is Bernstein's Top Pick for 2026
Jan 20, 2026 09:21AM Bernstein SocGen Group Downgrades Amgen (AMGN) to Market Perform
Jan 13, 2026 05:35AM Amgen (AMGN) PT Raised to $304 at BofA Securities
Jan 8, 2026 11:18AM Amgen (AMGN) call put ratio 1 call to 5.3 puts into the annual J.P. Morgan Healthcare Conference
Jan 7, 2026 04:58AM UBS Assumes Amgen (AMGN) at Buy
Jan 6, 2026 09:01AM Amgen acquires Dark Blue Therapeutics for up to $840 million
Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note
Dec 21, 2025 08:00PM Here's the list of top biotech stocks to own for 2026
View Older Stories